A previous study reported that a gene homologous to ANKRD1 (ankyrin repeat domain 1[cardiac muscle]) is associated with the platinum sensitivity in ovarian cancer cell lines, and decreasing ANKRD1 expression is a potential strategy to sensitize tumors to platinum-based drugs [44]. This evidence concerns the gene ANKRD1 and ovarian carcinoma.